Haematopoietic stem cell differentiation promotes the release of prominin-1/CD133-containing membrane vesicles--a role of the endocytic-exocytic pathway
about
The Evolution of the Stem Cell Theory for Heart FailureExosomes and Their Therapeutic Potentials of Stem CellsMicroRNAs are shaping the hematopoietic landscapeCD133/prominin-1-mediated autophagy and glucose uptake beneficial for hepatoma cell survivalSelective lentiviral gene delivery to CD133-expressing human glioblastoma stem cellsCD133 is a modifier of hematopoietic progenitor frequencies but is dispensable for the maintenance of mouse hematopoietic stem cells.Biochemical and biological characterization of exosomes containing prominin-1/CD133.Phenotypic, Morphological and Adhesive Differences of Human Hematopoietic Progenitor Cells Cultured on Murine versus Human Mesenchymal Stromal Cells.Human prominin-1 (CD133) is detected in both neoplastic and non-neoplastic salivary gland diseases and released into saliva in a ubiquitinated form.Urinary CD133+ extracellular vesicles are decreased in kidney transplanted patients with slow graft function and vascular damage.Spatial distribution of prominin-1 (CD133)-positive cells within germinative zones of the vertebrate brain.Proteome profiling of neuroblastoma-derived exosomes reveal the expression of proteins potentially involved in tumor progressionCD133-targeted gene transfer into long-term repopulating hematopoietic stem cellsCD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like CellsTetraspanin CD9 determines invasiveness and tumorigenicity of human breast cancer cellsWnt interaction and extracellular release of prominin-1/CD133 in human malignant melanoma cells.TrkB-containing exosomes promote the transfer of glioblastoma aggressiveness to YKL-40-inactivated glioblastoma cells.Resistance of glioma cells to nutrient-deprived microenvironment can be enhanced by CD133-mediated autophagy.CD133-Positive Membrane Particles in Cerebrospinal Fluid of Patients with Inflammatory and Degenerative Neurological DiseasesCD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges.Identification of novel human leukocyte antigen-A*0201-restricted, cytotoxic T lymphocyte epitopes on CD133 for cancer stem cell immunotherapy.Membrane lipid rafts, master regulators of hematopoietic stem cell retention in bone marrow and their trafficking.Stem cell-derived exosomes: roles in stromal remodeling, tumor progression, and cancer immunotherapy.Integrated time-lapse and single-cell transcription studies highlight the variable and dynamic nature of human hematopoietic cell fate commitment.Extracellular Vesicles: Evolving Factors in Stem Cell Biology.Proliferating versus differentiating stem and cancer cells exhibit distinct midbody-release behaviour.CD133 is essential for glioblastoma stem cell maintenance.Comments on the "Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer" and the "Commentary by Antonio Ieni and Giovanni Tuccari".Extracellular vesicles in the urine: markers and mediators of tissue damage and regeneration.Prominin-1/CD133: Lipid Raft Association, Detergent Resistance, and Immunodetection.Therapeutic Potential of Hematopoietic Stem Cell-Derived Exosomes in Cardiovascular Disease.Control of AC133/CD133 and impact on human hematopoietic progenitor cells through nucleolin.The HDAC6 Inhibitor Tubacin Induces Release of CD133+ Extracellular Vesicles From Cancer Cells.Letter to the editor: An intriguing relationship between lipid droplets, cholesterol-binding protein CD133 and Wnt/β-catenin signaling pathway in carcinogenesis.Stem-Cell-Based Therapies for Vascular Regeneration in Peripheral Artery DiseasesIsolation and Characterization of Extracellular Vesicles in Stem Cell-Related StudiesCytoplasmic CD133 expression correlates with histologic differentiation and is a significant prognostic factor in extrahepatic bile duct cancer and gallbladder cancer
P2860
Q26769042-E4DD9450-9E2D-48A3-928C-41FD554C5052Q26771909-887BAF72-D3FD-467C-932C-56FD1C1E09B8Q27027663-80FEF751-4CC6-4D38-8379-327F035EA310Q27313878-A263C690-7594-4A29-A1E9-F1346CBD6115Q27318247-DB41A302-B9EF-471D-B6A5-D5F05E8E57C6Q30538464-69209E07-A86E-4ADE-B6FD-D2AA614997B1Q30541069-5C3FFB33-A5C8-45EC-8FE6-ED319DB7C806Q30670619-1D37BD49-E3FA-405C-85A4-02F99001162EQ33728631-8C6BDD15-DFC8-4607-B742-57427DD87A4FQ34011337-88B15EC2-D44A-40ED-B59F-6E5F830D49BEQ34749277-82BD572C-04A8-42E3-98FC-480ECB2BF37CQ34999444-725C1CF3-E69E-4EF3-BD6D-3C2B8B61E24FQ35238704-5FDEED86-AB65-4291-8CFC-A7C6AF52C182Q35666904-395C1ACB-40D2-4BC4-ACE4-AE800F37436DQ35781480-34A452AB-3546-4B64-8F07-E570779E2A85Q36673662-75555423-A6D7-45B5-ACD9-EB1AD7D2152AQ37580396-B5F56A01-2AA6-4698-98B0-FFECB9CEFE7CQ37689095-3459F419-C972-454A-AB9E-EEF2666F8B80Q37721224-4DCA3A62-B2D8-4DBD-BAA2-1BA3B43E0948Q38035206-0545D664-A66B-4957-90B2-0F2B53789E95Q38266427-C6AE50B6-B3EA-4FE6-997D-674208835236Q38369838-2D0C5A40-5F82-4666-9C85-4E8F1711FE88Q38586627-31DDAFF8-9068-4B40-BFF5-8327CA525B4BQ38657573-8232A704-7783-4502-9F73-660CD4026D47Q38663473-F1291876-91D0-4289-98C3-ABF77978FD6BQ38924455-F2FE6D81-ADD8-471B-8029-256F86682688Q39212552-6EC5A974-0E40-4743-B882-67CD46B04EDDQ41350562-521BF4C7-A719-4FF8-BD57-628B627CB5EFQ42154903-ECDAF135-C13A-4FB8-9DE6-300B9E7A1C3FQ47225574-B79B2950-90BB-442E-9BC4-296B17083B41Q47763374-9B9640E5-9A9C-45A1-9303-5A0204395313Q48157628-E2AE8DD1-6939-4F22-ABBD-8154CC26C844Q48220409-CB6ACA61-6CB9-4E40-B5A2-ABB091DE3CB5Q53644558-0FA7D8F1-5C1E-4F3E-947F-5159B9F0286FQ57767168-29C8F685-6890-4140-88B3-2A5016F1E334Q58226894-43355D6B-8581-49EF-A566-62DDA6112CA4Q58572653-5651B846-1384-420F-8B2B-0AB4F83AD441
P2860
Haematopoietic stem cell differentiation promotes the release of prominin-1/CD133-containing membrane vesicles--a role of the endocytic-exocytic pathway
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Haematopoietic stem cell diffe ...... the endocytic-exocytic pathway
@en
type
label
Haematopoietic stem cell diffe ...... the endocytic-exocytic pathway
@en
prefLabel
Haematopoietic stem cell diffe ...... the endocytic-exocytic pathway
@en
P2093
P2860
P356
P1476
Haematopoietic stem cell diffe ...... the endocytic-exocytic pathway
@en
P2093
Ana-Violeta Fonseca
Christoph Thiele
Daniel Freund
Denis Corbeil
Doreen Strauss
Jana Karbanová
Michaela Wilsch-Bräuninger
Nicola Bauer
Wieland B Huttner
P2860
P304
P356
10.1002/EMMM.201100147
P577
2011-05-18T00:00:00Z